Upexi (NASDAQ:GRVI) Trading Down 1.8%

Upexi, Inc. (NASDAQ:GRVIGet Free Report) traded down 1.8% during trading on Tuesday . The stock traded as low as $1.65 and last traded at $1.68. 24,211 shares were traded during trading, a decline of 65% from the average session volume of 68,280 shares. The stock had previously closed at $1.71.

Upexi Stock Performance

The company has a 50 day simple moving average of $1.97 and a 200 day simple moving average of $3.10.

Institutional Trading of Upexi

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Geode Capital Management LLC grew its holdings in shares of Upexi by 13.0% during the fourth quarter. Geode Capital Management LLC now owns 59,632 shares of the company’s stock worth $178,000 after purchasing an additional 6,863 shares during the last quarter. BlackRock Inc. grew its holdings in shares of Upexi by 237.5% during the first quarter. BlackRock Inc. now owns 19,765 shares of the company’s stock worth $100,000 after purchasing an additional 13,909 shares during the last quarter. Renaissance Technologies LLC bought a new stake in shares of Upexi during the second quarter worth about $78,000. Finally, Vanguard Group Inc. grew its holdings in shares of Upexi by 28.1% during the third quarter. Vanguard Group Inc. now owns 120,122 shares of the company’s stock worth $465,000 after purchasing an additional 26,338 shares during the last quarter. 1.79% of the stock is currently owned by institutional investors.

About Upexi

(Get Free Report)

Grove, Inc, through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors.

Featured Stories

Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.